Application NoteImproved Chromatographic Analysis of Oligonucleotides with ACQUITY PREMIER Oligonucleotide BEH C18 Columns
Applications | 2020 | WatersInstrumentation
Therapeutic oligonucleotides such as antisense sequences, siRNA and mRNA vaccines are emerging in drug development and diagnostics. Accurate chromatographic analysis ensures reliable quality control, potency assessment and method repeatability.
This work evaluates non-specific adsorption of oligonucleotides on metallic LC hardware and demonstrates how ACQUITY PREMIER Oligonucleotide BEH C18 Columns with MaxPeak HPS surfaces eliminate sample loss and improve analytical performance.
The study comprised:
Key instrumentation:
Experiments revealed significant oligonucleotide adsorption on stainless steel frits, with up to 29 % recovery loss even after 50 injections at neutral pH. Acidic conditions (pH 5) exacerbated adsorption, while alkaline pH (7–8) reduced but did not eliminate losses. Transient conditioning was observed: repeated injections temporarily saturate metal binding sites but prolonged mobile phase flushing causes de-conditioning and peak variability. PREMIER columns equipped with MaxPeak HPS hardware achieved near-complete recovery from the first injection across pH 6–8.5, demonstrating permanent mitigation of surface adsorption.
This approach offers:
Advancements in surface chemistry and HPS technologies may extend to other analytes prone to metal interactions, such as phosphopeptides and organophosphates. Integration with high-throughput LC-MS platforms and further miniaturization could enhance sensitivity in genomic and clinical applications.
Non-specific adsorption on metallic LC components poses a significant challenge in oligonucleotide analysis. Elevating mobile phase pH offers limited relief. MaxPeak HPS hardware in ACQUITY PREMIER columns provides a robust solution, delivering reliable, out-of-the-box performance and increasing confidence in quantitative oligonucleotide assays.
Consumables, HPLC, LC columns
IndustriesClinical Research
ManufacturerWaters
Summary
Importance of the Topic
Therapeutic oligonucleotides such as antisense sequences, siRNA and mRNA vaccines are emerging in drug development and diagnostics. Accurate chromatographic analysis ensures reliable quality control, potency assessment and method repeatability.
Study Objectives and Overview
This work evaluates non-specific adsorption of oligonucleotides on metallic LC hardware and demonstrates how ACQUITY PREMIER Oligonucleotide BEH C18 Columns with MaxPeak HPS surfaces eliminate sample loss and improve analytical performance.
Methodology and Instrumentation
The study comprised:
- MISER experiments with 2.1 mm stainless steel frits and PEEK unions to quantify adsorption of a 25-mer phosphorothioate oligonucleotide at varying mobile phase pH values.
- Ion-pair reversed-phase UPLC separations of 15 to 35 mer oligodeoxythymidine standards using hexylammonium acetate mobile phases at pH 6–8.5.
- Comparative analysis on conventional stainless steel columns versus PREMIER columns under identical gradient and temperature conditions.
Key instrumentation:
- ACQUITY UPLC H-Class Bio system conditioned with oligodeoxythymidine.
- ACQUITY PREMIER Oligonucleotide BEH C18 Columns, 130 Å, 1.7 µm, 2.1×50 mm.
- Empower 3.0 chromatography data software.
- UV detection at 260 nm with titanium 5 µL flow cell.
Main Results and Discussion
Experiments revealed significant oligonucleotide adsorption on stainless steel frits, with up to 29 % recovery loss even after 50 injections at neutral pH. Acidic conditions (pH 5) exacerbated adsorption, while alkaline pH (7–8) reduced but did not eliminate losses. Transient conditioning was observed: repeated injections temporarily saturate metal binding sites but prolonged mobile phase flushing causes de-conditioning and peak variability. PREMIER columns equipped with MaxPeak HPS hardware achieved near-complete recovery from the first injection across pH 6–8.5, demonstrating permanent mitigation of surface adsorption.
Benefits and Practical Applications
This approach offers:
- Elimination of extended column conditioning protocols.
- Consistent, high-recovery analysis for trace and preparative oligonucleotide samples.
- Improved reproducibility and quantitation accuracy in LC-UV and LC-MS workflows.
Future Trends and Possibilities
Advancements in surface chemistry and HPS technologies may extend to other analytes prone to metal interactions, such as phosphopeptides and organophosphates. Integration with high-throughput LC-MS platforms and further miniaturization could enhance sensitivity in genomic and clinical applications.
Conclusion
Non-specific adsorption on metallic LC components poses a significant challenge in oligonucleotide analysis. Elevating mobile phase pH offers limited relief. MaxPeak HPS hardware in ACQUITY PREMIER columns provides a robust solution, delivering reliable, out-of-the-box performance and increasing confidence in quantitative oligonucleotide assays.
References
- Gilar M et al. Oligonucleotides 2003, 13(4), 229–243.
- McCarthy SM et al. Anal. Biochem. 2009, 390(2), 181–188.
- Basiri B et al. J. Chromatogr. A 2019, 1584, 97–105.
- Pardi N et al. Nat. Rev. Drug Discov. 2018, 17(4), 261–279.
- Gilar M, Bouvier ESP. J. Chromatogr. A 2000, 890(1), 167–177.
- Gilar M. Anal. Biochem. 2001, 298(2), 196–206.
- Gilar M et al. J. Chromatogr. A 2002, 958(1-2), 167–182.
- Li N et al. J. Chromatogr. A 2018, 1580, 110–119.
- Gong L, McCullagh JS. Rapid Commun. Mass Spectrom. 2014, 28(4), 339–350.
- Sturm M et al. Nucleic Acids Res. 2007, 35(12), 4195–4202.
- Gilar M et al. Waters Application Note, 2007.
- Wyndham KD et al. Anal. Chem. 2003, 75(24), 6781–6788.
- Ivleva VB. Waters Application Note, 2008.
- Huber CG et al. Anal. Biochem. 1993, 212(2), 351–358.
- Huber CG et al. Nucleic Acids Res. 1993, 21(5), 1061–1066.
- McCarthy SM, Gilar M. Waters Application Note, 2010.
- Shlyankevich A. TIDES, 2010.
- Tuytten R et al. J. Chromatogr. A 2006, 1104(1-2), 209–221.
- Walter TH et al. J. Chromatogr. A 2020, submitted.
- Chen S et al. J. Chromatogr. Sci. 2014, 52(8), 950–953.
- Welch CJ et al. Tetrahedron: Asymmetry 2010, 21(13-14), 1674–1681.
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.
Similar PDF
Improving Recovery and Quantitation of Oligonucleotide Impurities Using ACQUITY PREMIER with MaxPeak HPS Technology
2021|Waters|Applications
Application Note Improving Recovery and Quantitation of Oligonucleotide Impurities Using ACQUITY PREMIER with MaxPeak HPS Technology Brooke M. Koshel, Robert E. Birdsall, Ying Qing Yu Waters Corporation Abstract Ion-pair reversed-phase chromatography is a commonly used technique for the separation of…
Key words
premier, premieroligonucleotide, oligonucleotideacquity, acquitymaxpeak, maxpeakhps, hpssystem, systemtechnology, technologyoligonucleotides, oligonucleotidesimpurities, impuritiesconventional, conventionalsurfaces, surfacespassivation, passivationminutes, minutesrecovery, recoveryusing
Mitigation of Non-Specific Adsorption During Column Conditioning for an Oligonucleotide HILIC Analysis
2025|Waters|Applications
Application Note Mitigation of Non-Specific Adsorption During Column Conditioning for an Oligonucleotide HILIC Analysis Tony Reinhold, Martin Gilar, Andrew Steere, Paula Hong Waters Corporation Abstract Oligonucleotides, the short strands of nucleic acids that are pivotal in genetic research and therapeutic…
Key words
mitigation, mitigationhilic, hilicadsorption, adsorptionoligonucleotide, oligonucleotideconditioning, conditioningmaxpeak, maxpeakhps, hpsnon, nonspecific, specificalliance, alliancecolumn, columnduring, duringhplc, hplcpassivation, passivationstainless
Low Adsorption HPLC Columns Based on MaxPeak High Performance Surfaces
2020|Waters|Technical notes
[ WHITE PAPER ] Low Adsorption HPLC Columns Based on MaxPeak High Performance Surfaces M. Lauber, T. H. Walter, M. Gilar, M. DeLano, C. Boissel, K. Smith, R. Birdsall, P. Rainville, J. Belanger, and K. Wyndham Waters Corporation, Milford, MA,…
Key words
maxpeak, maxpeakhps, hpssurfaces, surfacesadsorption, adsorptionmetal, metalpremier, premiersurface, surfacecolumns, columnspaper, paperwhite, whiteperformance, performancehardware, hardwarehigh, highhplc, hplccolumn
Analysis of siRNA Drugs at Denaturing UPLC Conditions Using MaxPeak Premier Column Technology
2021|Waters|Applications
Application Note Analysis of siRNA Drugs at Denaturing UPLC Conditions Using MaxPeak Premier Column Technology Irene Suarez Marina, Willy Verluyten, Evelien Dejaegere, Leslie Napoletano, J-P. Boon, Mario Hellings, Martin Gilar Janssen Pharmaceutical Companies of Johnson & Johnson, Waters Corporation Abstract…
Key words
sirna, sirnamaxpeak, maxpeakdenaturing, denaturingpremier, premierdrugs, drugsuplc, uplctechnology, technologycolumn, columnconditions, conditionsanalysis, analysisusing, usingoligonucleotide, oligonucleotideduplex, duplexsurfaces, surfacesacquity